logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Dec 11, 2017

PharmaCyte Biotech Meets with Oncology Advisory Board

  • Dec 5, 2017

PharmaCyte Biotech Announces Production of Master Cell Bank

  • Nov 28, 2017

PharmaCyte Biotech Announces Successful Completion of Cell Testing for Production of Master Cell Bank

  • Nov 16, 2017

British Columbia Securities Commission Revokes Cease Trade Order on PharmaCyte Biotech Securities

  • Nov 3, 2017

PharmaCyte Biotech Releases Shareholder Call Playback Information

  • Oct 27, 2017

PharmaCyte Biotech Update on Shareholder Call

  • Oct 20, 2017

PharmaCyte Biotech to Hold Shareholder Call

  • Oct 17, 2017

PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer

  • Oct 10, 2017

PharmaCyte Biotech Appoints Dr. Raymond Tong to Board of Directors

  • Sep 13, 2017

PharmaCyte Biotech Appoints Alan Morell of Creative Management Partners as Strategic Advisor

RSS
  • 1
  • 2
  • 3
  • 4
  • Next »

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites May 23, 2022
  • PharmaCyte Biotech to Attend 15th International Conference on Advanced Technologies and Treatments for Diabetes April 27, 2022